Insights and Resources

  1. Home
  2. Insights and Resources

Case Studies

E-Globex Case Study

TA Securities Case Study

Infographics

Challenges of Bribery and Corruption Prevention - Infographic

De-risking Dilemma

Fintech in Asia Pacific - Emergence of Fintech

Fintech in Asia Pacific - Future Role of Technology

Fintech in Asia Pacific - The Sandbox Concept

How Terrorists Secure & Spend Funding

Identify Terrorist Financing Risk Before It Impacts Your Business

True Cost of AML Compliance - Business

True Cost of AML Compliance - Overview

True Cost of AML Compliance - Staff

True Cost of AML Compliance - Italy

True Cost of AML Compliance - Switzerland

True Cost of AML Compliance - The Netherlands

Research

True Cost of AML Compliance APAC Survey Report

Videos

Bringing Science To Risk

Bringing-Science-To-Risk

De-Risking Dilemma


Drivers for AML Compliance

Financial Inclusion and Transparency - Mike Shaw at SIBOS 2016

Financial Inclusion and Transparency - The Role of the Risk Information Ecosystem


Indirect Costs of AML Compliance

Know Your Customer (KYC) Utilities - Tom Brown at SIBOS 2016

LexisNexis Risk Solutions Bridger Insight XG


Operational Challenges of AML Compliance

De-Risking Dilemma

LexisNexis Risk Solutions Bridger Insight XG

Financial Inclusion and Transparency - Mike Shaw at SIBOS 2016


Solving Global Risk Challenges

Solving-Global-Risk-Challenges

Financial Inclusion and Transparency - The Role of the Risk Information Ecosystem


Technology and AML Compliance

Technology-and-AML-Compliance


Indirect Costs of AML Compliance


Operational Challenges of AML Compliance


Solving Global Risk Challenges

Solving-Global-Risk-Challenges

Case Studies

Anti-Money Laundering policy guidelines

Anti-Money Laundering controls in Mergers & Acquisitions

Challenges of Beneficial Ownership

FCPA Enforcement - What Does it Mean for Non -US Companies

Financial Transparency and Inclusion Survey

Fintech in Asia - The Virtuous Circle

Fraud and Money Laundering - Can you think like a bad guy

Political Corruption and the Assessment of Politically Exposed Persons

Some Issues for Pharmaceutical Companies Under the FCPA

The Challenges of Terrorists Financing in 2013 and Beyond

The Early Lesson from GSK - How Real is Your Compliance Program

The Role of the Board of Directors in FCPA Compliance

Ultimate Beneficial Ownership - The Implications of Not Knowing

Understanding the new payment methods, their risks, and opportunities